Formulary Restriction of Selective Serotonin Reuptake Inhibitors for Depression: Potential Pitfalls

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.10, 2001-01, pp. : 973-982

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Serotonin Reuptake Inhibitors for Late-Life Depression: A Comparative Review

By Solai L.K.

Drugs & Aging, Vol. 18, Iss. 5, 2001-01 ,pp. : 355-368

Adis International

Access to resources Recommend Favorite

Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression

By Mace S. Taylor D.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 5, 2000-07 ,pp. : 917-933

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Depression in Acute Coronary Syndromes with Selective Serotonin Reuptake Inhibitors

By van Melle Joost P.

Drugs, Vol. 66, Iss. 16, 2006-01 ,pp. : 2095-2107

Adis International

Access to resources Recommend Favorite

The Economics of Selective Serotonin Reuptake Inhibitors In Depression: A Critical Review

By Frank L. Revicki D.A. Sorensen S.V. Shih Y-C.T.

CNS Drugs, Vol. 15, Iss. 1, 2001-01 ,pp. : 59-83

Adis International

Access to resources Recommend Favorite

Risks and Benefits of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression

By Mourilhe P. Stokes P.E.

Drug Safety, Vol. 18, Iss. 1, 1998-01 ,pp. : 57-82

Adis International

Access to resources Recommend Favorite